Variable genotype-phenotype correlations in patients with a rare nondeletional α-thalassemia; Hb Pak Num Po (HBA1: C.396-397insT)

Journal of Pediatric Hematology/Oncology

Volumn 36, Issue 3, 2014, Pages

  Sanpakit, Kleebsabai ^a   Viprakasit, Vip ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Hb H Hb Pak Num Po; Transfusion dependent thalassemia; transplantation

Indexed keywords

DEFEROXAMINE; FERRITIN; FOLIC ACID; HEMOGLOBIN ALPHA CHAIN; MULTIVITAMIN;

ADULT; ALPHA GLOBIN GENE; ALPHA THALASSEMIA; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CHILD; CHOLECYSTECTOMY; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; FEVER; GENE; GENE INSERTION; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HEPATOMEGALY; HEPATOSPLENOMEGALY; HETEROZYGOSITY; HISTOPATHOLOGY; HLA MATCHING; HUMAN; HUMAN CELL; IRON CHELATION; JAUNDICE; LIVER BIOPSY; MALE; MEAN CORPUSCULAR VOLUME; MIDDLE AGED; PRIORITY JOURNAL; SCHOOL CHILD; SPLENECTOMY; SPLENOMEGALY; THAILAND; YOUNG ADULT;

ADULT; ALPHA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS; SEQUENCE DELETION; SURVIVAL RATE;

EID: 84897518205     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000016     Document Type: Article

References (26)

1. Viprakasit V. Global epidemiology of beta-, Hb E, alphathalassaemia and SCD-specific reference to Asia. Thalassemia Rep. 2012;2(s1):22-23
2. Viprakasit V, Lee-Lee C, Chong QT, et al. Iron chelation therapy in the management of thalassemia: The Asian perspectives. Int J Hematol. 2009;90:435-445
3. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: An increasing global health problem. Bull World Health Organ. 2001;79:704-712
4. Weatherall DJ. The definition and epidemiology of non-transfusion- dependent thalassemia. Blood Rev. 2012;26(suppl 1):S3-S6
5. Higgs DR, Engel JD, Stamatoyannopoulos G. Thalassaemia. Lancet. 2012;379:373-383
6. Higgs DR. The molecular basis of alpha-thalassemia. Cold Spring Harb Perspect Med. 2013;3:a011718
7. Viprakasit V. Alpha-thalassemia syndromes: From clinical and molecular diagnosis to bedside management. EHA Educational Book. 2013;7:329-338
8. Fucharoen S, Viprakasit V. Hb H disease: Clinical course and disease modifiers. Hematology Am Soc Hematol Educ Program. 2009;1:26-34
9. Chui DH. Alpha-thalassemia: Hb H disease and Hb Barts hydrops fetalis. Ann N Y Acad Sci. 2005;1054:25-32
10. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86:480-487
11. Chen FE, Ooi C, Ha SY, et al. Genetic and clinical features of hemoglobin H disease in Chinese patients. N Engl JMed. 2000; 343:544-550
12. Laosombat V, Viprakasit V, Chotsampancharoen T, et al. Clinical features and molecular analysis in Thai patients with Hb H disease. Ann Hematol. 2009;88:1185-1192
13. Singer ST. Variable clinical phenotypes of alpha-thalassemia syndromes. Scientific World Journal. 2009;9:615-625
14. Chan V, Chan TK, Liang ST, et al. Hydrops fetalis due to an unusual form of Hb H disease. Blood. 1985;66:224-228
15. Chan V, Chan VW, Tang M, et al. Molecular defects in Hb H hydrops fetalis. Br J Haematol. 1997;96:224-228
16. Viprakasit V, Green S, Height S, et al. Hb H hydrops fetalis syndrome associated with the interaction of two common determinants of alpha thalassaemia (-MED/(alpha)TSaudi (alpha)). Br J Haematol. 2002;117:759-762
17. Li DZ, Liao C, Li J, et al. Hemoglobin H hydrops fetalis syndrome resulting from the association of the-SEA deletion and the alphaQuong Szealpha mutation in a Chinese woman. Eur J Haematol. 2005;75:259-261
18. Henderson S, Pitman M, McCarthy J, et al. Molecular prenatal diagnosis of Hb H hydrops fetalis caused by haemoglobin Adana and the implications to antenatal screening for alpha-thalassaemia. Prenat Diagn. 2008;28:859-861
19. Viprakasit V, Tanphaichitr VS, Veerakul G, et al. Coinheritance of Hb Pak Num Po, a novel alpha1 gene mutation, and alpha0 thalassemia associated with transfusion-dependent Hb H disease. Am J Hematol. 2004;75:157-163
20. Sura T, Busabaratana M, Youngcharoen S, et al. Haemoglobin Hope in a northern Thai family: First identification of homozygous haemoglobin hope associated with haemoglobin H disease. Eur J Haematol. 2007;79:251-254
21. Tan AS, Quah TC, Low PS, et al. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for alphathalassemia. Blood. 2001;98:250-251
22. Viprakasit V, Tanphaichitr VS, Pung-Amritt P, et al. Clinical phenotypes and molecular characterization of Hb H-Pakse disease. Haematologica. 2002;87:117-125
23. Saiviroonporn P, Viprakasit V, Maneesai A, et al. Inter-site validations of the Pixel-Wise method for cardiac T2 analysis in transfusion-dependent Thai thalassemia patients. J Med Assoc Thai. 2012;95(suppl 2):S165-S172
24. Saiviroonporn P, Viprakasit V, Boonyasirinant T, et al. Comparison of the region-based and pixel-wise methods for cardiac T2 analysis in 50 transfusion-dependent Thai thalassemia patients. J Comput Assist Tomogr. 2011;35:375-381
25. Viprakasit V. Hemoglobin Pak NUm Po (Hb PNP), a novel unorthodox alpha hemoglobin variant causing severe form of alpha thalassemia. Siriraj Med J. 2005;57:477-478
26. Schrier SL, Bunyaratvej A, Khuhapinant A, et al. The unusual pathobiology of hemoglobin constant spring red blood cells. Blood. 1997;89:1762-1769